FTC Tightens Antitrust Watch on Pharma as Patent Expiries Loom for Blockbuster Drugs Including Keytruda, Eliquis, Darzalex
Philadelphia: The U.S. Federal Trade Commission is on the lookout for anticompetitive practices in the pharmaceutical industry with a number of blockbuster drugs near the end of their patents, the…